CCL2 and Hepatic fibrosis: Then, an anti‐CCL2 antibody (4 μg per mouse, i.v.)or an equal amount of control antibody (IgG2b) was given to the liver fibrosis mice 3 h after cell infusion, and this procedure was repeated twice a week for two weeks (Figure 6g).